Medtronic Foresees Gradual ICD Uptake, Reviews Battery Problem
This article was originally published in The Gray Sheet
Executive Summary
Demand for Medtronic's implantable cardioverter defibrillators in response to CMS' January coverage decision will increase gradually over the next several quarters rather than in one dramatic surge, according to the company